- Previous Close
41.15 - Open
53.49 - Bid 41.64 x --
- Ask 41.68 x --
- Day's Range
41.43 - 43.69 - 52 Week Range
31.30 - 59.94 - Volume
2,435,050 - Avg. Volume
1,951,202 - Market Cap (intraday)
5.003B - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
45.81 - EPS (TTM)
0.91 - Earnings Date --
- Forward Dividend & Yield 1.20 (2.40%)
- Ex-Dividend Date Jan 24, 2025
- 1y Target Est
49.08
Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China.
www.acrobiosystems.cnRecent News: 301080.SZ
View MorePerformance Overview: 301080.SZ
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 301080.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 301080.SZ
View MoreValuation Measures
Market Cap
4.94B
Enterprise Value
3.18B
Trailing P/E
45.25
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.29
Price/Book (mrq)
1.92
Enterprise Value/Revenue
5.35
Enterprise Value/EBITDA
29.69
Financial Highlights
Profitability and Income Statement
Profit Margin
18.32%
Return on Assets (ttm)
1.03%
Return on Equity (ttm)
4.13%
Revenue (ttm)
594.56M
Net Income Avi to Common (ttm)
108.93M
Diluted EPS (ttm)
0.91
Balance Sheet and Cash Flow
Total Cash (mrq)
1.85B
Total Debt/Equity (mrq)
3.75%
Levered Free Cash Flow (ttm)
-106.24M